[Modification of the cytogenetic effect of dioxidine in experimental alloxan diabetes in rats]. 1985

G N Zolotareva, and I V Berezovskaia, and I M Sysoeva, and V I Rymartsev, and V V Otradnova

A dependence was established between the cytogenetic effect of dioxydinum antibacterial drug and the disturbance of carbohydrate metabolism in rats with alloxan diabetes.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D008677 Metaphase The phase of cell nucleus division following PROMETAPHASE, in which the CHROMOSOMES line up across the equatorial plane of the SPINDLE APPARATUS prior to separation.
D009153 Mutagens Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. Clastogen,Clastogens,Genotoxin,Genotoxins,Mutagen
D011810 Quinoxalines Quinoxaline
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D003921 Diabetes Mellitus, Experimental Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY. Alloxan Diabetes,Streptozocin Diabetes,Streptozotocin Diabetes,Experimental Diabetes Mellitus,Diabete, Streptozocin,Diabetes, Alloxan,Diabetes, Streptozocin,Diabetes, Streptozotocin,Streptozocin Diabete
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug

Related Publications

G N Zolotareva, and I V Berezovskaia, and I M Sysoeva, and V I Rymartsev, and V V Otradnova
January 1958, Diabetes,
G N Zolotareva, and I V Berezovskaia, and I M Sysoeva, and V I Rymartsev, and V V Otradnova
February 1964, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
G N Zolotareva, and I V Berezovskaia, and I M Sysoeva, and V I Rymartsev, and V V Otradnova
August 1953, Orvosi hetilap,
G N Zolotareva, and I V Berezovskaia, and I M Sysoeva, and V I Rymartsev, and V V Otradnova
January 1978, Farmakologiia i toksikologiia,
G N Zolotareva, and I V Berezovskaia, and I M Sysoeva, and V I Rymartsev, and V V Otradnova
December 1974, Minerva medica,
G N Zolotareva, and I V Berezovskaia, and I M Sysoeva, and V I Rymartsev, and V V Otradnova
January 1954, Medychnyi zhurnal,
G N Zolotareva, and I V Berezovskaia, and I M Sysoeva, and V I Rymartsev, and V V Otradnova
October 1969, Kardiologiia,
G N Zolotareva, and I V Berezovskaia, and I M Sysoeva, and V I Rymartsev, and V V Otradnova
June 1952, Gazzetta medica italiana,
G N Zolotareva, and I V Berezovskaia, and I M Sysoeva, and V I Rymartsev, and V V Otradnova
January 2000, Eksperimental'naia i klinicheskaia farmakologiia,
G N Zolotareva, and I V Berezovskaia, and I M Sysoeva, and V I Rymartsev, and V V Otradnova
January 1947, Federation proceedings,
Copied contents to your clipboard!